Repligen Corporation
RGEN
$111.49
$1.371.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.82% | 3.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.82% | 3.53% | |||
| Cost of Revenue | 6.56% | -1.21% | |||
| Gross Profit | 3.30% | 8.09% | |||
| SG&A Expenses | 0.95% | 6.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.09% | 1.96% | |||
| Operating Income | 28.96% | 31.79% | |||
| Income Before Tax | 11.69% | -6.06% | |||
| Income Tax Expenses | 164.70% | -34.28% | |||
| Earnings from Continuing Operations | -10.89% | 0.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.89% | 0.30% | |||
| EBIT | 28.96% | 31.79% | |||
| EBITDA | 11.05% | 10.05% | |||
| EPS Basic | -10.94% | 0.23% | |||
| Normalized Basic EPS | 35.63% | -7.04% | |||
| EPS Diluted | -11.50% | 0.00% | |||
| Normalized Diluted EPS | 35.45% | -7.07% | |||
| Average Basic Shares Outstanding | 0.08% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.22% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||